Scientists dig into DNA of moles to uncover hidden mutations

NCT ID NCT03054584

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study collects moles and blood samples from 50 adults to analyze the genetic mutations that cause moles to form. Researchers will compare DNA from mole tissue with normal DNA from blood to find specific changes. No treatments or interventions are given—the goal is purely to understand the genetic basis of melanocytic nevi.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could reveal which genetic changes cause moles to form, potentially guiding future studies on skin cancer.

What could go wrong

This is an observational study with no treatment, so it won't directly help patients. Results may not lead to new therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOCYTIC NEVI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

melanocytic nevus Nevus, Pigmented

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California-Davis, Department of Dermatology

    RECRUITING

    Sacramento, California, 95816, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••